NO20015288D0 - Anvendelse av makrolide forbindelser for behandling av tört öye - Google Patents

Anvendelse av makrolide forbindelser for behandling av tört öye

Info

Publication number
NO20015288D0
NO20015288D0 NO20015288A NO20015288A NO20015288D0 NO 20015288 D0 NO20015288 D0 NO 20015288D0 NO 20015288 A NO20015288 A NO 20015288A NO 20015288 A NO20015288 A NO 20015288A NO 20015288 D0 NO20015288 D0 NO 20015288D0
Authority
NO
Norway
Prior art keywords
treatment
dry eye
macrolide compounds
macrolide
compounds
Prior art date
Application number
NO20015288A
Other languages
English (en)
Other versions
NO20015288L (no
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22452015&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20015288(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of NO20015288D0 publication Critical patent/NO20015288D0/no
Publication of NO20015288L publication Critical patent/NO20015288L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
NO20015288A 1999-04-30 2001-10-29 Anvendelse av makrolide forbindelser for behandling av tört vye NO20015288L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13200999P 1999-04-30 1999-04-30
PCT/JP2000/002756 WO2000066122A1 (en) 1999-04-30 2000-04-26 Use of macrolide compounds for the treatment of dry eye

Publications (2)

Publication Number Publication Date
NO20015288D0 true NO20015288D0 (no) 2001-10-29
NO20015288L NO20015288L (no) 2001-10-29

Family

ID=22452015

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015288A NO20015288L (no) 1999-04-30 2001-10-29 Anvendelse av makrolide forbindelser for behandling av tört vye

Country Status (23)

Country Link
EP (1) EP1173177B2 (no)
JP (2) JP5036934B2 (no)
KR (1) KR20020015316A (no)
CN (1) CN1190194C (no)
AR (1) AR023807A1 (no)
AT (1) ATE281167T1 (no)
AU (1) AU777915B2 (no)
BR (1) BR0011225A (no)
CA (1) CA2372448A1 (no)
CZ (1) CZ20013769A3 (no)
DE (1) DE60015516T2 (no)
ES (1) ES2232439T3 (no)
HK (2) HK1043321B (no)
HU (1) HUP0200864A3 (no)
IL (1) IL146162A0 (no)
MX (1) MXPA01010988A (no)
NO (1) NO20015288L (no)
NZ (1) NZ515339A (no)
PT (1) PT1173177E (no)
TR (1) TR200103119T2 (no)
TW (1) TWI230066B (no)
WO (1) WO2000066122A1 (no)
ZA (1) ZA200108905B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1173177B2 (en) * 1999-04-30 2014-03-05 Sucampo AG Use of macrolide compounds for the treatment of dry eye
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
CN1259049C (zh) 2001-07-06 2006-06-14 苏坎波公司 包含白介素－2抑制剂和抗菌剂的局部给药组合物
AR038628A1 (es) * 2002-03-04 2005-01-19 Novartis Ag Composicion oftalmica
CA2495103A1 (en) * 2002-08-09 2004-02-19 Sucampo Pharmaceuticals, Inc. Pharmaceutical compositions comprising fk506 derivatives and their use for the treatment of allergic diseases
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
AR042890A1 (es) * 2003-01-16 2005-07-06 Sucampo Pharmaceuticals Inc Metodo de tratamiento del ojo seco con una composicion oftalmica que contiene un compuesto macrolido
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
US7083802B2 (en) * 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
CN1863522A (zh) 2003-10-06 2006-11-15 欧得士株式会社 治疗泪液异常用的眼科用组合物
ES2564194T3 (es) 2005-02-09 2016-03-18 Santen Pharmaceutical Co., Ltd. Formulaciones líquidas para el tratamiento de enfermedades o dolencias
PL1904056T3 (pl) 2005-07-18 2009-09-30 Minu Llc Zastosowanie makrolidu do przywracania czucia rogówkowego
BRPI0707612B8 (pt) 2006-02-09 2021-05-25 Macusight Inc vaso lacrado e formulações líquidas contidas no mesmo
US8222271B2 (en) 2006-03-23 2012-07-17 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
EP2335735A1 (en) * 2009-12-14 2011-06-22 Novaliq GmbH Pharmaceutical composition for treatment of dry eye syndrome
CN111278401B (zh) * 2017-05-30 2023-08-15 艾克思摩尔有限公司 递送抗生素大环内酯治疗干眼综合征的组合物和方法
US11766421B2 (en) 2017-09-25 2023-09-26 Surface Ophthalmics, Inc. Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU635286B2 (en) * 1989-07-05 1993-03-18 Astellas Pharma Inc. Aqueous liquid composition for external use
DE69231644T2 (de) * 1991-04-26 2001-05-23 Fujisawa Pharmaceutical Co Verwendung von makrolid-verbindungen gegen augenerkrankungen
ZA924953B (en) * 1991-07-25 1993-04-28 Univ Louisville Res Found Method of treating ocular inflammation
AR004480A1 (es) * 1995-04-06 1998-12-16 Amico Derin C D Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
US6673807B1 (en) * 1998-04-06 2004-01-06 Fujisawa Pharmaceutical Co., Ltd. Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins
CN1161117C (zh) * 1998-04-27 2004-08-11 藤泽药品工业株式会社 药物组合物
US6376517B1 (en) * 1998-08-14 2002-04-23 Gpi Nil Holdings, Inc. Pipecolic acid derivatives for vision and memory disorders
EP1173177B2 (en) * 1999-04-30 2014-03-05 Sucampo AG Use of macrolide compounds for the treatment of dry eye

Also Published As

Publication number Publication date
CA2372448A1 (en) 2000-11-09
ES2232439T3 (es) 2005-06-01
PT1173177E (pt) 2005-03-31
NZ515339A (en) 2004-02-27
DE60015516T2 (de) 2005-12-01
HUP0200864A3 (en) 2004-07-28
DE60015516D1 (de) 2004-12-09
KR20020015316A (ko) 2002-02-27
JP2002543132A (ja) 2002-12-17
TWI230066B (en) 2005-04-01
BR0011225A (pt) 2002-03-19
TR200103119T2 (tr) 2002-04-22
EP1173177A1 (en) 2002-01-23
JP2012116857A (ja) 2012-06-21
HK1043321B (zh) 2005-07-15
IL146162A0 (en) 2002-07-25
HK1046099A1 (zh) 2002-12-27
AU777915B2 (en) 2004-11-04
MXPA01010988A (es) 2004-04-21
AU4142900A (en) 2000-11-17
CN1190194C (zh) 2005-02-23
HUP0200864A2 (hu) 2002-07-29
EP1173177B1 (en) 2004-11-03
CZ20013769A3 (cs) 2002-03-13
CN1353608A (zh) 2002-06-12
JP5036934B2 (ja) 2012-09-26
HK1043321A1 (en) 2002-09-13
NO20015288L (no) 2001-10-29
EP1173177B2 (en) 2014-03-05
WO2000066122A1 (en) 2000-11-09
ATE281167T1 (de) 2004-11-15
AR023807A1 (es) 2002-09-04
ZA200108905B (en) 2002-12-24

Similar Documents

Publication Publication Date Title
NO20014379D0 (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20021474D0 (no) Forbindelser for behandling av ischemi
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20015288D0 (no) Anvendelse av makrolide forbindelser for behandling av tört öye
NO20013380L (no) 2-aminobenzoksazinonderivater for behandling av fedme
DE60028014D1 (de) Steuerbare endoskophülle
FI20000863A (fi) Uusi hoitomenetelmä
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
NO20013381D0 (no) 2-oksybenzoksazinonderivater for behandling av fedme
PT1235831E (pt) Novos compostos de oxabispidina uteis no tratamento de arritmias cardiacas
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO20022245D0 (no) Onkolyttiske kombinasjoner for behandling av cancer
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
NO20020784D0 (no) Medikament for behandling av brudd
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20013385L (no) S-nitrosotioler som midler for behandling av sirkulatoriske dysfunksjoner
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
PT1140090E (pt) Utilizacao de fanquinona para o tratamento ou prevencao da perda de memoria
NO20005856L (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application